10-4162

antibody from ABEOMICS Inc.
Targeting: MS4A1 B1, Bp35, CD20, MS4A2
Provider product page for 10-4162

Antibody data

Product number
10-4162 - Provider product page
Provider
ABEOMICS Inc.
Product name
Anti-CD20 Antibody
Antibody type
Monoclonal
Description
CD20 is clinically validated as an immunotherapy target for B-cell lymphomas and autoimmune diseases. CD20 consists of large, intracellular, amino- and carboxyterminal portions connected by 4 membrane-spanning domains. Its high expression on malignant B cells and its reported lack of shedding from the surfacemake CD20 an ideal target for antibody-mediated killing. Anti-CD20 antibodies are believed to mediate the therapeutic effect by activation of complement-dependent cytotoxicity (CDC) and largely by antibody-dependent cellular cytotoxicity exerted by recruitment of innate immune effector cells expressing the Fcgamma receptor IIIa.
Reactivity
Human
Host
Mouse
Conjugate
Unconjugated
Antigen sequence
A partial length recombinant protei
n corresponding to extra cellular d
omain of CD20 was used as the immun
ogen for this antibody.
Isotype
IgG
Antibody clone number
ABM46C7
Vial size
100 µg
Concentration
0.5 mg/ml
Storage
Store the antibody at 4°C, stable for 6 months. For long-term storage, store at -20°C. Avoid repeat freez thawing
MS4A1 protein structure - 10-4162 shown in red.